CC5

Clever Culture Systems wins second major order from AstraZeneca for APAS Independence instruments

Recently rebranded Clever Culture Systems (ASX: CC5) continues to see success with its strategy targeting the pharmaceutical environmental monitoring market, selling a further four of its APAS Independence instruments to multinational pharmaceutical and biotechnology company AstraZeneca. Formerly known as LBT Innovations, this is the company’s second order from AstraZeneca and follows the decision in August […]